Table 3.

Factors Associated With Increased Platelet phosphoACC in CAD Patients (>0.5 AU Threshold)

	OR (95% CI)	p Value
Aspirin treatment	1.16 (0.54–2.51)	0.70
DAPT	1.50 (0.68–3.34)	0.32
D-dimer (log transformed)	0.62 (0.20–1.94)	0.41
hsCRP (log transformed)	1.00 (0.58–1.71)	0.99
Non-HDL	1.00 (0.99–1.01)	0.53
TG	1.00 (1.00–1.01)	0.048∗
HDL	0.97 (0.96–1.00)	0.043∗
TG/HDL-C ratio (log transformed)	3.97 (1.25–12.61)	0.019∗

DAPT = dual antiplatelet therapy; other abbreviations as in Tables 1 and 2.

^∗Statistical significance when p value <0.05.